These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39043640)

  • 1. Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants.
    Shetty NS; Gaonkar M; Patel N; Pampana A; Vekariya N; Li P; Arora G; Arora P
    Nat Commun; 2024 Jul; 15(1):6221. PubMed ID: 39043640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults.
    Coniglio AC; Segar MW; Loungani RS; Savla JJ; Grodin JL; Fox ER; Garg S; de Lemos JA; Berry JD; Drazner MH; Shah S; Hall ME; Shah A; Khan SS; Mentz RJ; Pandey A
    JACC Heart Fail; 2022 Feb; 10(2):129-138. PubMed ID: 35115086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
    Parker MM; Damrauer SM; Tcheandjieu C; Erbe D; Aldinc E; Hawkins PN; Gillmore JD; Hull LE; Lynch JA; Joseph J; Ticau S; Flynn-Carroll AO; Deaton AM; Ward LD; Assimes TL; Tsao PS; Chang KM; Rader DJ; Fitzgerald K; Vaishnaw AK; Hinkle G; Nioi P
    Sci Rep; 2021 Jun; 11(1):11645. PubMed ID: 34079032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
    JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Burden of the V142I Transthyretin Variant.
    Selvaraj S; Claggett B; Shah SH; Mentz RJ; Khouri MG; Manichaikul AW; Khan SS; Rich SS; Mosley TH; Levitan EB; Arora P; Goyal P; Haring B; Eaton CB; Cheng RK; Wells GL; Manson JE; Fontana M; Solomon SD
    JAMA; 2024 Jun; 331(21):1824-1833. PubMed ID: 38734952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.
    Greve AM; Christoffersen M; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
    JAMA Cardiol; 2021 Mar; 6(3):258-266. PubMed ID: 33237279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
    Parcha V; Malla G; Irvin MR; Armstrong ND; Judd SE; Lange LA; Maurer MS; Levitan EB; Goyal P; Arora G; Arora P
    JAMA; 2022 Apr; 327(14):1368-1378. PubMed ID: 35377943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank.
    Parker MM; Ticau S; Butler J; Erbe D; Merkel M; Aldinc E; Hinkle G; Nioi P
    Amyloid; 2020 Sep; 27(3):184-190. PubMed ID: 32425064
    [No Abstract]   [Full Text] [Related]  

  • 9. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
    Razvi Y; Ioannou A; Patel RK; Chacko L; Karia N; Riefolo M; Porcari A; Rauf MU; Starr N; Ganesananthan S; Blakeney I; Kaza N; Filisetti S; Bolhuis RE; Rowczenio D; Gilbertson J; Hutt D; Mahmood S; Lachmann HJ; Wechalekar AD; Kotecha T; Knight DS; Coghlan JG; Petrie A; Whelan CJ; Venneri L; Martinez-Naharro A; Hawkins P; Fontana M; Gillmore JD
    Eur J Heart Fail; 2024 Feb; 26(2):383-393. PubMed ID: 37953725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of cardiovascular outcomes and mortality assessed by the C-reactive protein to albumin ratio in the UK Biobank.
    Wändell P; Carlsson AC; Larsson AO; Ärnlöv J; Ruge T; Rydell A
    BMC Cardiovasc Disord; 2024 Jun; 24(1):326. PubMed ID: 38926672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amyloidogenic V122I transthyretin variant in elderly black Americans.
    Quarta CC; Buxbaum JN; Shah AM; Falk RH; Claggett B; Kitzman DW; Mosley TH; Butler KR; Boerwinkle E; Solomon SD
    N Engl J Med; 2015 Jan; 372(1):21-9. PubMed ID: 25551524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
    Kozlitina J; Garg S; Drazner MH; Matulevicius SA; Ayers C; Overton J; Reid J; Baras A; Rao K; Pandey A; Berry J; de Lemos JA; Grodin JL
    J Card Fail; 2022 Mar; 28(3):403-414. PubMed ID: 34634447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience.
    Rowczenio D; Quarta CC; Fontana M; Whelan CJ; Martinez-Naharro A; Trojer H; Baginska A; Ferguson SM; Gilbertson J; Rezk T; Sachchithanantham S; Mahmood S; Manwani R; Sharpley F; Wechalekar AD; Hawkins PN; Gillmore JD; Lachmann HJ
    Hum Mutat; 2019 Jan; 40(1):90-96. PubMed ID: 30328212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population.
    Aung N; Nicholls HL; Chahal CAA; Khanji MY; Rauseo E; Chadalavada S; Petersen SE; Munroe PB; Elliott PM; Lopes LR
    JAMA Cardiol; 2024 Nov; 9(11):964-972. PubMed ID: 39196575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
    Bhuiyan T; Helmke S; Patel AR; Ruberg FL; Packman J; Cheung K; Grogan D; Maurer MS
    Circ Heart Fail; 2011 Mar; 4(2):121-8. PubMed ID: 21191093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of the dietary inflammatory potential with risk of overall and site-specific cancers: A community-based longitudinal study in the UK Biobank.
    Liang J; Yang R; Da H; Wang J; Maimaitiyiming M; Qi X; Dunk MM; Xu W
    J Nutr Health Aging; 2024 Jun; 28(6):100225. PubMed ID: 38582035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity.
    Buxbaum J; Koziol J; Connors LH
    Amyloid; 2008 Dec; 15(4):255-61. PubMed ID: 19065297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I
    Hendren NS; De Lemos JA; Berry JD; Kozlitina J; Saelices L; Ji AX; Shao Z; Liu CF; Garg S; Farr MA; Drazner MH; Tang WHW; Grodin JL
    Amyloid; 2024 Jun; 31(2):124-131. PubMed ID: 38445629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carpal Tunnel Syndrome and Transthyretin Amyloidosis in the All of Us Research Program.
    Shetty NS; Pampana A; Patel N; Maurer MS; Goyal P; Li P; Arora G; Arora P
    Mayo Clin Proc; 2024 Jul; 99(7):1101-1111. PubMed ID: 38661598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank.
    Lim J; Hashemian M; Blechter B; Roger VL; Wong JYY
    Eur J Heart Fail; 2024 Mar; 26(3):540-550. PubMed ID: 38528787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.